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Alternative polyadenylation factors link cell
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Abstract
Background: In response to a wound, fibroblasts are activated to migrate toward the wound, to proliferate and to
contribute to the wound healing process. We hypothesize that changes in pre-mRNA processing occurring as
fibroblasts enter the proliferative cell cycle are also important for promoting their migration.
Results: RNA sequencing of fibroblasts induced into quiescence by contact inhibition reveals downregulation of
genes involved in mRNA processing, including splicing and cleavage and polyadenylation factors. These genes also
show differential exon use, especially increased intron retention in quiescent fibroblasts compared to proliferating
fibroblasts. Mapping the 3′ ends of transcripts reveals that longer transcripts from distal polyadenylation sites are
more prevalent in quiescent fibroblasts and are associated with increased expression and transcript stabilization
based on genome-wide transcript decay analysis. Analysis of dermal excisional wounds in mice reveals that
proliferating cells adjacent to wounds express higher levels of cleavage and polyadenylation factors than quiescent
fibroblasts in unwounded skin. Quiescent fibroblasts contain reduced levels of the cleavage and polyadenylation
factor CstF-64. CstF-64 knockdown recapitulates changes in isoform selection and gene expression associated with
quiescence, and results in slower migration.
Conclusions: Our findings support cleavage and polyadenylation factors as a link between cellular proliferation
state and migration.
Keywords: mRNA processing, Proliferation, Quiescence, Migration, Wound healing
Background
Fibroblasts within the dermis bear much of the responsi-
bility for the secretion and maintenance of extracellular
matrix proteins [1]. Fibroblasts in unwounded skin are
mostly in a state of quiescence in which they have revers-
ibly exited the proliferative cell cycle [1–3]. In the initial
response to a wound, mitogens and chemokines such as
platelet-derived growth factor and fibroblast growth factor
released by platelets and keratinocytes stimulate fibro-
blasts to migrate to the wound-healing environment and
proliferate [1–4]. In the wounded tissue, fibroblasts
secrete collagen and other extracellular matrix molecules
that remodel the extracellular environment and promote
the formation of a scar [3]. While fibroblasts are recog-
nized to play an important role in normal skin and in the
wound-healing environment, we do not yet have a full ap-
preciation of the molecular mechanisms that control the
changes in fibroblast behavior in the context of a wound.
We have been studying the transition between prolifera-
tion and quiescence in a model system in primary human
dermal fibroblasts [5–9]. Using microarrays, we and
others have shown that a shift between proliferation and
quiescence is associated with a major reprogramming of
gene expression patterns, and that these gene expression
changes are important for the functional attributes of qui-
escent cells, such as their ability to re-enter the cell cycle
[9–12]. Based on our previous studies showing changes in
the levels of splicing factors as fibroblasts transition be-
tween proliferation and quiescence [9], and earlier studies
showing that proliferating cells, stem cells, activated cells,
and cancer cells rely heavily on alternative polyadenylation
(APA) by preferential use of proximal polyadenylation
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sites [13–21], we sought to understand whether alternative
isoform use [16, 22, 23] could represent a link between
proliferation and migration.
To address this question, we defined the changes in iso-
form use and polyadenylation site selection that occur as
cells transition from proliferation to quiescence. We found
that APA factors are expressed at lower levels as fibroblasts
become quiescent, and that knockdown of these factors re-
sults in APA and gene expression changes that overlap with
the changes that occur with quiescence. Longer transcripts
that end at distal polyadenylation sites tend to be more
stable than shorter transcripts generated from proximal
polyadenylation site use in proliferating cells. We also dis-
covered that APA factors are functionally important for the
transition to a more migratory state in proliferating versus
quiescent fibroblasts and affect migration in cancer cells as
well. Our data, taken as a whole, provide a deeper under-
standing of the role of mRNA processing in the close asso-
ciation between proliferation and migration.
Results
Entry into quiescence results in downregulation of genes
involved in the cell cycle, mRNA processing, and motility
Primary human dermal fibroblasts were isolated from
human skin samples as previously described [24]. Fibro-
blasts isolated from two different donors were collected
in proliferating conditions or after being induced into
quiescence by 7 days of contact inhibition (7dCI) of pro-
liferation [7]. RNA-Seq and microarray analyses were
performed to determine changes in gene expression be-
tween three samples of proliferating and matched 7dCI
cells (Fig. 1a and Additional file 1: Table S1) [25].
Among the 19,673 genes monitored, transcripts from
1993 genes (10.1%) changed in expression twofold or
more, demonstrating widespread changes in gene
expression with contact inhibition-induced quiescence
(Fig. 1b). Expression levels for 52% of these genes were
upregulated in 7dCI compared with proliferating fibro-
blasts, and 48% were downregulated in 7dCI fibroblasts.
Fig. 1 RNA-Seq analysis of gene expression changes in proliferating versus quiescent fibroblasts. a Schematic of RNA-Seq-based analysis of
proliferating and quiescent fibroblasts performed in this study. b Total RNA was isolated from three independent biological replicates of
proliferating fibroblasts and three matched independent biological replicates of 7dCI fibroblasts. RNA samples were converted to cDNA libraries
and sequenced on an Illumina Hi-Seq 2000. Reads were aligned to the human genome (hg19 human reference sequence) and the number of
reads mapping to each gene (UCSC gene annotation) in the genome was determined. A heatmap of read counts for 1993 genes with at least a
twofold change in expression and a false discovery rate (FDR) < 5% is shown. Hierarchical clustering is denoted by the dendrogram to the left of
the heatmap. A color key and a histogram displaying the density of genes at a given color intensity are shown in the upper left corner. c Gene
set enrichment analysis was used to determine the gene sets most significantly upregulated (top) or downregulated (bottom) with quiescence.
Gene sets are listed in descending order of statistical significance from left to right. A histogram of the log2(fold-change) of the normalized read
count in 7dCI compared to proliferating fibroblasts for each gene in the gene set is plotted in a violin plot representation. d Heat maps of genes
within selected gene set enrichment categories are provided. The log2 ratio of normalized RNA-Seq counts in 7dCI compared with proliferating
fibroblasts are shown. Red indicates higher expression in quiescent than proliferating fibroblasts; green indicates higher expression in proliferating
than quiescent fibroblasts. Only genes in each category that change in expression two-fold or more are included
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Correlation between biological replicates analyzed by
RNA-Seq was high (R2 values greater than or equal to 0.83)
(Additional file 1: Figure S1A). When the same samples
were analyzed with microarrays, the differential gene ex-
pression detected by microarray was largely in agreement
with that detected by RNA-Seq (r2 = 0.785, p < 0.001) (Add-
itional file 1: Figure S1B). Further, gene expression changes
detected by RNA-Seq correlated well with the previously
published “quiescence program” of gene expression
changes identified in fibroblasts induced into quiescence by
multiple independent conditions [9] (Additional file 1: Fig-
ure S1C). The findings support previous studies showing
that quiescence is associated with regulation of a significant
fraction of the genome [9, 10, 26].
Gene set enrichment analysis (GSEA) [27, 28] revealed
that expression of genes involved in DNA replication
and cell cycle regulation was downregulated in 7dCI
compared with proliferating fibroblasts (Fig. 1c), consist-
ent with cell cycle exit in contact-inhibited conditions.
Expression of genes associated with extracellular matrix
remodeling and collagen metabolism was upregulated
with quiescence (Fig. 1c, d), consistent with our previous
findings [6, 7]. Indeed, COL21A1, a collagen found asso-
ciated with collagen I, is among the genes most strongly
induced in quiescent compared with proliferating fibro-
blasts (Additional file 1: Table S2). Expression of genes
in the categories of muscle filament sliding, regulation of
muscle contraction, movement, and muscle contraction
was downregulated in contact-inhibited compared with
proliferating fibroblasts (Fig. 1c, d). Four genes involved
in cell motility were among the most strongly downregu-
lated genes with quiescence (KISS1, ACTC1, PODXL,
and RLTPR) (Table 1 and Additional file 1: Table S2).
Thus, we found that proliferating fibroblasts express
higher levels of transcripts associated with motility and
cytoskeletal remodeling.
Transcripts associated with splicing and polyadenyla-
tion were mostly downregulated in 7dCI compared with
proliferating fibroblasts (Fig. 1c, d), consistent with pre-
vious reports [9, 21]. Transcripts encoding many of the
proteins that are considered core components of the
spliceosome were slightly downregulated in contact-
inhibited compared with proliferating fibroblasts (Add-
itional file 1: Table S3), with three genes reaching statis-
tical significance (U1C (2.26-fold reduction), PRPF4
(2.77-fold reduction), and PPIH (2.89-fold reduction)).
Expression levels of cleavage and polyadenylation factors
were also reduced with quiescence (Additional file 2).
We hypothesized that in addition to changes in gene
expression, alterations in mRNA processing events be-
tween proliferating and quiescent fibroblasts could also
contribute to functional changes in quiescent and prolif-
erating states.
Quiescent fibroblasts retain more exons and introns than
proliferating fibroblasts
To better understand changes in mRNA processing associ-
ated with proliferation, we investigated our RNA-Seq data
further to identify examples of alternative start site, alterna-
tive splicing, or alternative polyadenylation. Applying the
DEXSeq algorithm [29], we discovered 1975 exons,
encoded within 1218 genes, with differential expression be-
tween proliferating and 7dCI fibroblasts (Additional file 3).
Using g:Profiler [30], we found that genes that undergo
alternative isoform expression in proliferating versus quies-
cent cells are enriched in categories of RNA binding, RNA
processing, translational elongation, and RNA splicing
(Table 2, Additional file 4). Thus, genes involved in RNA
processing are themselves particularly likely to be alterna-
tively processed during the transition between proliferation
and quiescence.
To better understand the frequency of specific types of
splicing events that occurred differentially in proliferating
and quiescent fibroblasts, we applied the rMATS compu-
tational algorithm [31–33] (Fig. 2a, Additional file 5).
Skipped exons (exons that are present in proliferating, but
Table 1 List of genes involved in motility that are altered with quiescence
Type of change (analysis) Genes
Differential expression (DESeq) KISS1, ACTC1, PODXL, RLTPR, PDPN, PALM, MYLIP, DNALI1, ADRA2A, KAL1, LYPD3, TNFRSF12A,
ARHGDIB, ACTR3, ACTG1, MSN, PAK4, ARHGDIA, ACTB, TUBB, PTGS2, TPM1, PLAUR, TPM3
Alternative splicing (rMATS) FYN, HGF, CD44, MAP4, ATP2B4, MYLK, ACTN1, SCARB1, FGFR1, FAT1, MYL6, TSPO, AKT2, BRAT1,
ARHGAP21, GTPBP4, SOD2, FN1, WIPF1, CD58, KIF17, ITGB1BP1, GLIPR2, CALD1, LRP1, KLC1, KTN1,
CHN1, POSTN, NUMB, ENPP2, KIF13A, TPM1, CLTC, MINK1, SH3KBP1, CACNA1C, DAB2, THY1, NCK1,
SHC1, NFASC, IL17RC, LAMB2, PTPRM, GAS6, CCDC125, LAMA2, FLNA, SPTAN1, TPM2, CDC42BPB
UTR-type alternative polyadenylation for 2pA
site-containing genes
MACF1, LMNA, DDR2, LAMC1, NAV1, PEX13, ACTR2, IL1R1, MYO1B, SP100, TRAK1, NCK1, OPA1,
PDGFRA, AP3S1, TUBB, PTP4A1, FGFR1OP, ANLN, GLIPR2, AMOTL1, PTPN11, MMP14, FRMD6,
SMAD3, DYNLL2, PTPRA, DOK5, COL18A1, SSX2IP, NRAS, CERS2, SDC1, DPP4, DYNC1LI1, MAP4,
WNT5A, CD47, DPYSL3, LAMA4, ARHGAP18, CITED2, GNA12, STC1, EXT1, AP3M1, BLOC1S2,
RRAS2, TBX5, SYNJ2BP, EMP2, AMFR, STAT3, COL1A1, CCBE1, AP3D1, SDC4, APP, RBFOX2,
MYH9, RAP2C
Upstream region-type alternative polyadenylation
for 2 pA site-containing genes
RDX, PEX14, DYNC2LI1, SUN1, RECK, IQGAP1, DOCK7
Mitra et al. Genome Biology          (2018) 19:176 Page 3 of 24
not quiescent, cells or vice versa) were the most common
type of event detected (319 events, 53% of events). Of the
splicing events detected by rMATS, 39% were also de-
tected by DEXSeq. More exons were preferentially in-
cluded in quiescent compared with proliferating
conditions, than proliferating compared with quiescent
conditions (1.5-fold, Fisher’s exact test, two-tailed p value
= 0.013) (Fig. 2a). These exon-switching events provide
opportunities for regulation of protein function based on
the inclusion or exclusion of individual exons. Introns
were significantly more frequently retained in quiescent
than proliferating fibroblasts (3.7-fold, Fisher’s exact test,
two-tailed p value < 0.0001) (Fig. 2a). 8.2% of the tran-
scripts associated with retained intron events are anno-
tated as nonsense-mediated decay (NMD) candidates (18
unique NMD transcripts/220 total unique intron retention
transcripts in the Ensembl database). Gene ontology (GO)
analysis of the differentially spliced genes revealed that
genes that undergo alternative splicing with quiescence
are enriched for the categories of RNA binding, RNA pro-
cessing, and RNA splicing (Table 2 and Additional file 6),
consistent with a growing literature demonstrating that
genes involved in mRNA splicing are themselves regulated
by splicing events [30, 34–37].
Some auxiliary splicing factors are downregulated in
quiescent fibroblasts
To understand the changes in splicing in quiescent com-
pared with proliferating fibroblasts, we investigated changes
in the expression of splicing factors. Our RNA-Seq data re-
vealed that expression from RNA splicing genes is modestly
downregulated in contact-inhibited fibroblasts (Fig. 1c, d
and Additional file 1: Table S3). We monitored protein
levels of splicing factors with immunoblotting in fibroblasts
that were proliferating or induced into quiescence by 7 days
of contact inhibition (7dCI) or by serum starvation (7dSS).
Levels of essential splicing factor U2AF65 were similar in
proliferating and quiescent fibroblasts. Levels of core factor
U1-70K and auxiliary factors TRA2β and FUS were down-
regulated in quiescent compared with contact-inhibited
fibroblasts (Fig. 2b). Lower levels of some splicing factors in
quiescent fibroblasts may contribute to the increased intron
retention in quiescent conditions [38, 39].
Weaker splice sites for retained introns
In addition to lower levels of splicing factors, intron
retention has been associated with weak splice sites [40,
41]. To better understand why some introns are retained
in proliferating or quiescent cells, we analyzed the extent
to which 5′ splice sites (9-nt length) and 3′ splice sites
(23 nt) of differentially retained introns match consensus
splice sites [42]. We determined the probability of ob-
serving each sequence given the position weight matrix
for consensus splice sites. Sequences at splice sites for
introns differentially retained in proliferating or quies-
cent states matched the consensus sequence less well
than the sequences near constitutively spliced exons,
with a strong effect at the 3′ splice site (Fig. 2c). These
findings are consistent with previous studies that also
showed that 3′ splice sites are enriched for C’s compared
with T’s in the polypyrimidine tracts of introns that are
retained [43]. Thus, in proliferating fibroblasts that have
higher levels of most splicing factors, intron retention
may be especially sensitive to the 3′ splice sequence.
A shift toward the use of more distal polyadenylation
sites in quiescence
A shift toward the use of distal polyadenylation sites has
been observed in previous studies that showed that
non-dividing cells [21] and differentiated cells [18, 20,
44, 45] predominantly use distal polyadenylation sites,
while proliferating cells [18, 21] and cancer cell lines [20,
45, 46] tend to use proximal polyadenylation sites. Our
DEXSeq analysis revealed that many of the changes in
isoform expression detected between proliferating and
7dCI fibroblasts involve the last exon of the analyzed
Table 2 List of splicing genes undergoing differential pre-mRNA processing with quiescence
Type of pre-mRNA processing (analysis) Splicing genes
Differential exon use (DEXSeq) KDM1A, LUC7L, AQR, ZCCHC8, SFSWAP, U2AF2, SUGP2, SNRPA, YTHDC1, FUS, PAPOLA, HNRNPC,
HNRNPH3, HNRNPM, POLR2E, SNU13, RBFOX2, SRSF5, ACIN1, PABPC1L, USB1, SNRNP70, RBM28,
LSM5, CASC3, LUC7L3, DHX15, MAGOHB, SRSF9, SRSF3, PAPOLG, SF3B1, SRSF7, SRSF4, SFPQ,
SRSF11, RBM25, DDX39A, SRSF6, RBM39, SNRPA1, ZRANB2, SRRM1, RBM17, CCNH, RBMX2, TRA2B,
HNRNPD, SCAF11, SNRPG, SNRNP200, SREK1, RNF20, CCAR2, U2AF1, CHTOP, ZNF326, TRA2A,
CDK12, SF1, HNRNPH1, RBM4B, RSRC1, GEMIN4, NPM1, SF3A3, PRPF39, ADARB1, UBL5
Alternative splicing (rMATS) LUC7L, ZCCHC8, SRRT, HNRNPC, HNRNPH3, NHP2L1, DDX17, RBM23, PRMT5, SRSF5, ACIN1,
PQBP1, SNRNP70, POLR2I, DDX5, MAGOHB, SRSF3, PRPF4B, SF3B1, SRSF7, TIA1, SRSF11, RBM25,
DDX39A, SRSF6, SNRPB, DNAJC8, RBM39, SNRPA1, SRRM1, PNPT1, HNRNPD, SCAF11, MBNL1,
SREK1, AFF2, RBPMS, U2AF1, CHTOP, SRSF2, TRA2A, HNRNPH1, PRPF39, UBL5, DDX39B
UTR-type alternative polyadenylation for 2pA
site-containing genes
WDR77, SNRNP40, SF3A3, CHTOP, TSEN15, KHDRBS1, RBM17, HNRNPH3, CSTF3, RBM4B,
MAGOHB, SART3, CMTR2, TXNL4B, POLR2C, SF3B3, SRSF2, RNMT, GTF2F1, KHSRP, HNRNPUL1,
PTBP1, CIR1, TIA1, GCFC2, APP, RBFOX2, NHP2L1, POLDIP3, ISY1, NCBP2, RSRC1, POLR2H, PAPD4
Upstream region-type alternative polyadenylation
for 2 pA site-containing genes
HNRNPR, WBP11, RBBP6, SAFB2, PRPF4B, PSIP1, ZRSR2
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transcript and would result in a change in polyadenylation
site. For example, Inverted Formin, FH2 and WH2 do-
main (INF2), and brother of CDO (BOC) (Fig. 3a) exhibit
alternative use of terminal exons in proliferating and 7dCI
fibroblasts. Real-time PCR with isoform-specific primers
confirmed that for both INF2 and BOC, the transition to
quiescence in response to either 7dCI or 7dSS resulted in
a change in polyadenylation site selection (Fig. 3b). For
INF2, the strongest effect was a decrease in the use of the
proximal polyadenylation site. For BOC, the strongest
effect was an increase in the use of the distal polyadenyla-
tion site in quiescent fibroblasts. Restimulation of 7dCI fi-
broblasts to a proliferative state resulted in a reversal back
toward a polyadenylation site selection profile more simi-
lar to that in proliferating cells for both INF2 and BOC.
To generate a large-scale dataset that would clearly
define the 3′ ends of transcripts in proliferating and
quiescent (7dCI) fibroblasts, we applied polyadenylation
site-enriched RNA-Seq [47]. With polyadenylation
site-enriched RNA-Seq, ~ 64% of all mapped sequencing
Fig. 2 Differential splicing in proliferating and quiescent fibroblasts. a rMATS was applied to RNA-Seq data from three biological replicates of
proliferating fibroblasts and three biological replicates of contact-inhibited fibroblasts. Splicing events with an FDR < 0.05 are shown. The total
numbers of splicing events are reported. In parentheses, the number of events with higher inclusion in proliferating fibroblasts is provided,
followed by the number of events with higher inclusion in quiescent fibroblasts. Skipped exons were significantly more likely to be included in
quiescent fibroblasts (Fisher’s exact test, two-tailed p value = 0.013). Introns were significantly more likely to be retained in quiescent fibroblasts
(Fisher’s exact test, two-tailed p value < 0.0001). b Immunoblotting of splicing factors in proliferating and quiescent fibroblasts. Levels of core
splicing factor U2AF65 were similar in proliferating and quiescent fibroblasts. U1-70 K and auxiliary factors TRA2β and FUS were expressed at
lower levels in 7dCI and 7dSS compared with proliferating fibroblasts. α-Tubulin was analyzed as a loading control. The ratio of splicing factor to
tubulin, normalized to proliferating cells, is shown below. c Sequence logos [120] are provided for 5′ and 3′ sequences for exons that are
constitutively spliced, and introns that are preferentially retained in proliferating or quiescent cells. The y-axis indicates bits of information [121]. 3′
splice site sequences were different between proliferating versus constitutive conditions (p value < 0.01 for constitutive versus retained in
proliferating conditions, ANOVA with Tukey’s multiple comparison test) and quiescent versus constitutive conditions (p value < 0.01 for
constitutive versus retained in quiescent conditions)
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reads matched a polyadenylation site (Additional file 1:
Table S4). Polyadenylation site-enriched RNA-Seq data
were used to determine the relative use of the distal
(RUD) (reads mapping to the distal polyadenylation site/
total reads from proximal and distal polyadenylation
sites) for each gene in proliferating and 7dCI conditions
for detected genes with two polyadenylation sites
(Additional file 7). For genes with greater than two
polyadenylation sites (Additional file 8), a more general
parameter called relative site usage (reads mapping to a
polyadenylation site/total reads from all polyadenylation
sites) was used. Data were highly reproducible when dif-
ferent biological replicates of proliferating and 7dCI
samples were compared (Additional file 1: Figure S2A).
Using polyadenylation site-enriched RNA-Seq, we con-
firmed the previous finding [21] of a shift toward the use
of more distal polyadenylation sites upon entry into the
quiescent state through contact inhibition (Fig. 3c,
Additional file 7). Eighty-eight percent (628 out of 714)
of genes with two polyadenylation sites, and with signifi-
cant changes (|RUD| > 0.05) in alternative polyadenyla-
tion (APA) between the two cell states, were longer
(greater use of distal pA sites compared to proximal pA
sites) in the quiescent compared with the proliferating
fibroblasts. For 572 of these 628 genes (91%), the prox-
imal polyadenylation site localizes to the 3′ untranslated
region (UTR; termed as UTR APA) (Fig. 3c), while for
the remaining 9% of genes, the proximal polyadenylation
site is found in the region upstream of the 3´ UTR (up-
stream region (UR) APA) including introns and exons.
Genes with two polyadenylation sites that undergo APA
with quiescence were enriched in genes involved in RNA
Fig. 3 Use of distal polyadenylation sites and lower levels of cleavage and polyadenylation factors during quiescence. a UCSC Genome browser
views showing the long and short isoforms of INF2 and BOC. The differentially expressed exon is highlighted in cyan. b Real-time PCR validation
of APA with quiescence. cDNA samples generated from fibroblasts that were proliferating, quiescent by contact inhibition or serum starvation, or
induced into quiescence by serum-starvation and then restimulated, were analyzed with real-time PCR. Primers were designed to recognize the
short (terminating at the proximal polyadenylation site) or long (terminating at the distal polyadenylation site) isoforms of INF2 or BOC.
Transitioning fibroblasts into quiescence resulted in reduced expression of the short isoform of INF2 and increased expression of the long isoform
of BOC. Restimulating quiescent fibroblasts resulted in expression patterns of the short and long isoforms that more closely resemble proliferating
cells. Plots show individual datapoints as dots. Bar graphs represent mean and average ± S.D. The number of replicates for all conditions for short
and long INF2 is 3. The number of replicates for all conditions for long BOC is 3. The number of replicates for P, 7dCI, and 7dCI-R for short BOC is
3. The number of replicates for 7dSS for short BOC is 2. Statistical significance in knockdown cells compared to control cells was determined for
long and short isoforms with two-tailed, unpaired t tests. For all figures, one asterisk indicates p value < 0.05. Two asterisks indicate p value < 0.01.
Three asterisks indicate p value < 0.001. c A shift toward expression of longer isoforms in quiescent fibroblasts. Proliferating and 7dCI were
analyzed by polyadenylation site-enriched RNA-Seq. Relative use of the distal polyadenylation site (RUD) for individual genes in proliferating
fibroblasts is plotted on the x-axis and RUD for the same gene in quiescent conditions is plotted on the y-axis. The dashed black line indicates y
= x. The first plot (left) displays all genes with two detected polyadenylation sites. The middle plot displays UTR APA genes and the final plot
(right) shows the same data for genes that undergo UR APA. d Immunoblotting was performed on protein lysates collected from proliferating,
7dCI and 7dSS fibroblasts for CstF-64, CFIm25, and CPSF73. Phosphorylation of serine 5 on RNA pol II CTD was monitored by immunoblotting
and levels decline with quiescence. α-Tubulin was monitored as a loading control
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splicing and processing (Table 2 and Additional file 9).
Genes that undergo APA with quiescence also included
genes involved in cell migration (Table 1).
Reduced levels of mRNA processing factors in quiescent
fibroblasts
To better understand the regulation of polyadenylation
site use with quiescence, we monitored the levels of APA
factors in proliferating and quiescent fibroblasts. Cleavage
and polyadenylation of pre-mRNA transcripts are medi-
ated by the coordinated activity of three core protein com-
plexes [16]. The cleavage and polyadenylation specificity
factor (CPSF) complex recognizes a hexameric sequence
(AAUAAA or a similar sequence) in a 50-nt region
upstream of the cleavage site [48, 49]; the 3′ pre-RNA,
subunit 2, 64 kDa (CSTF2 or CstF-64) subunit of the CstF
complex recognizes a U-rich or G/U-rich region about
20–40 nucleotides downstream of the cleavage site [19,
50–53]; and Nudix (nucleoside diphosphate linked moiety
X)-type motif 21 (NUDT21 or CFIm25) recognizes UGUA
sequences upstream of the cleavage and polyadenylation
sites [54]. CPSF73, a component of the CPSF complex, is
the endonuclease that performs the cleavage event at the
hexameric sequence [55]. Increased levels of CSTF
complex proteins have been associated with the use of
proximal polyadenylation sites [19, 56, 57], while the
CFIm complex has been reported to repress the use of
proximal polyadenylation sites [45, 57, 58]. Our RNA-Seq
data revealed that most of the core polyadenylation factors
and auxiliary factors associated with cleavage and polyade-
nylation are modestly downregulated at the transcript
level in quiescent compared with proliferating fibroblasts
(Additional file 2). Among the core factors, CstF-64/
CSTF2 is strongly and significantly (3.1-fold) downregu-
lated at the transcript level. Using immunoblotting, we
found that the protein levels of CstF-64, CPSF73, and
CFIm25 are lower in 7dCI or 7dSS than in proliferating
fibroblasts (Fig. 3d). By monitoring the extent of Serine 5
phosphorylation of RNA pol II carboxyterminal domain
(CTD) as an indication of transcription initiation rate [59]
with immunoblotting, we found that CstF-64 downregula-
tion at the protein level with quiescence was stronger than
the reduction in transcription initiation (Fig. 3d).
Knockdown of cleavage and polyadenylation factors
replicates polyadenylation site selection with quiescence
To better understand the role of cleavage and polyade-
nylation factors in polyadenylation site selection with
quiescence, we introduced siRNAs that target CstF-64,
CPSF73 or CFIm25, or a control siRNA, into fibroblasts.
Strong knockdown of the targeted gene was confirmed
with real-time PCR (Additional file 1: Figure S3). In
comparison to control cells, knockdown of these polya-
denylation factors did not significantly affect cell viability
(Additional file 1: Figure S4A and B). We tested whether
knocking down the expression of cleavage and polyade-
nylation factors results in changes in the levels of shorter
and longer isoforms of genes that undergo APA with
quiescence using real-time PCR primers designed to
recognize the short or long isoforms of INF2 or BOC
(Fig. 3a). For INF2, knockdown of CstF-64 or CPSF73,
but not CFIm25, resulted in reduced levels of the short
isoform of INF2 and an increase in the long isoform of
INF2 (Fig. 4a). For BOC, knockdown of CstF-64 or
CPSF73, but not CFIm25, resulted in lower levels of the
short BOC isoform (Fig. 4a). Knockdown of CstF-64 re-
sulted in an increase in the long isoform of BOC (Fig. 4a).
To monitor global APA changes, we performed
polyadenylation site-enriched RNA-Seq of fibroblasts
transfected with a control siRNA or an siRNA that
targets a polyadenylation factor (CstF-64, CPSF73, or
CFIm25) [47]. Knockdown in two different strains of
fibroblasts resulted in highly reproducible results
(Additional file 1: Figure S2B). Each knockdown
resulted in significant changes (|RUD| > 0.05) in poly-
adenylation site selection, with CFIm25 knockdown
resulting in a clear shift toward use of more proximal
polyadenylation sites (Additional file 1: Figure S4C
and Additional file 10), consistent with previous re-
ports [60, 61]. We compared the genes that shift
polyadenylation site use with quiescence with the re-
sults of knockdown of each cleavage and polyadenyla-
tion factor (Fig. 4b and Additional file 1: Figure S5A
and B). Among the three polyadenylation factors,
knockdown of CFIm25 resulted in the largest number
of genes that shift to greater use of the proximal
polyadenylation site (shorter isoforms), and the most
genes that overlap with shifts to more proximal poly-
adenylation sites with quiescence (Fig. 4b and Add-
itional file 1: Figure S5A). We observed significant
overlap among the genes that use more distal polya-
denylation sites (shift to longer isoforms) with quies-
cence and genes that use more distal polyadenylation
sites with knockdown of each factor, with larger num-
bers of genes affected for CstF-64 or CPSF73 knock-
down (Fig. 4b and Additional file 1: Figure S5A).
Some of these changes in polyadenylation site use
were specific for one factor, while some were regu-
lated by more than one or even all three factors
(Additional file 1: Figure S5B). For 626 unique genes
that shift to distal polyadenylation site use with quies-
cence, 226 genes (36%) also shift to distal polyadeny-
lation site use with knockdown of one or more
polyadenylation factors. For 86 genes that shift to
proximal polyadenylation site use with quiescence, 38
(44%) also shift to proximal polyadenylation site use
with knockdown of one or more polyadenylation
factors (Additional file 1: Figure S5B).
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Knockdown of CstF-64 resulted in changes in gene ex-
pression that significantly overlap with gene expression
changes with quiescence (Fig. 4c and Additional file 11).
Gene expression changes upon knockdown of CPSF73
and CFIm25 overlapped with gene expression changes
during quiescence as well, but fewer genes were involved
(Additional file 1: Figure S5C).
Some of the genes that were regulated (APA changes
or gene expression changes) with knockdown of CstF-64
was found to be associated with GO terms related to cell
movement (Table 3). Several of these migration genes
that undergo changes in APA upon CstF64 knockdown
also did so with quiescence, such as Arp2/3 complex
protein ACTR2 and CDC42 and RAC1-binding protein
IQGAP1.
Cleavage and polyadenylation factor recognition sites are
more prevalent in genes that undergo alternative isoform
use with quiescence
To further understand the importance of different cleav-
age and polyadenylation site factors in the alternative
use of polyadenylation sites with quiescence, we
Fig. 4 Knockdown of cleavage and polyadenylation factors results in changes in isoform use and gene expression that overlap with quiescence.
a Knockdown of cleavage and polyadenylation factors induces a shift in isoform expression. Real-time PCR was performed for the short and long
isoforms of INF2 and BOC in proliferating fibroblasts expressing a control siRNA or an siRNA that targets CFIm25, CstF-64, or CPSF73. The short
isoform of INF2 or BOC was significantly reduced in cells transfected with an siRNA against CstF64 or CPSF73. Plots show individual datapoints as
dots. Bar graphs represent mean and average ± S.D. The number of replicates for control, CFIm25 and CPSF73 knockdown for short and long
INF2 is 6. The number of replicates for CstF64 knockdown for short and long INF2 is 3. The number of replicates for all conditions for long BOC is
2, except the control, which had 3 replicates. The number of replicates for control and CFIm25 knockdown for short BOC is 3. The number of
replicates for CstF64 and CPSF73 knockdown for short BOC is 2. Statistical significance in knockdown cells compared to control cells was
determined for long and short isoforms with two-tailed, unpaired t-tests. b Overlap among genes that undergo APA with quiescence and
knockdown of cleavage and polyadenylation factors. The overlap between genes that use the proximal polyadenylation site with quiescence and
use a proximal polyadenylation site preferentially with CFIm25 knockdown is shown on the left. Overlap between genes that use distal
polyadenylation sites with quiescence and genes that use distal polyadenylation sites with CPSF73 or CstF64 knockdown are shown in the
middle and the right, respectively. c Overlap between genes upregulated with quiescence and genes upregulated with CstF-64 knockdown (left)
and overlap between genes downregulated with quiescence and genes downregulated with CstF-64 knockdown (right). The overlap between
groups of genes was tested using the hypergeometric test
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monitored the presence of their recognition motifs
(Fig. 5a). For genes that undergo UR APA and shift to
greater use of more distal polyadenylation sites during
quiescence, their proximal polyadenylation site is more
likely to have a strong hexamer (AAUAAA or AUUA
AA), and less likely to have no hexamer, than for control
genes (Fig. 5b). Similarly, when CPSF73 is knocked
down, genes that shift to greater use of distal polyadeny-
lation sites are less likely to have no hexamer than genes
that do not lengthen with quiescence (Additional file 1:
Figure S6). The findings support a role for reduced
CPSF73 levels contributing to the use of more distal
polyadenylation sites in genes undergoing UR APA in
quiescent cells.
Extending the analysis to UGUA motifs recognized by
CFIm25, among genes that use UR APA to shift to more
distal polyadenylation site use in quiescent than prolifer-
ating cells, there was a significantly higher chance of a
UGUA motif being present at the proximal site than for
a control set of genes (Fig. 5c). With CFIm25 knock-
down, the strongest effect was increased use of proximal
polyadenylation sites, and the genes affected were more
likely to have a UGUA motif at their distal polyadenyla-
tion site (Additional file 1: Figure S7).
To monitor the presence of binding sites for CstF-64,
we determined the fraction of polyadenylation sites that
contain a string of four or more uracils in the region
20–40 base pairs downstream of the polaydenylation
site. With this analysis, there were more UUUU motifs
at proximal polyadenylation sites among genes that shift
to the use of more distal sites with quiescence, but the
difference was not statistically significant (0.098)
(Fig. 5d). We also monitored the fraction of U’s (U-rich)
and the fraction of U’s or G’s (UG-rich) in the same
20–40 base pair region. Proximal polyadenylation sites
were enriched in U-rich and UG-rich sequences for
genes that shifted to greater use of longer isoforms
with quiescence (Fig. 5e and Additional file 1: Figure
S8). This result is consistent with downregulation of
CstF-64 playing a role in the shift to more distal
polyadenylation sites with quiescence. Thus, in prolif-
erating conditions, CstF-64 levels are more available
for binding to U-rich proximal sites, which supports
the generation of shorter isoforms.
Shifting to more distal polyadenylation sites stabilizes
transcripts in quiescent but not proliferating fibroblasts
Changes in the levels of transcripts that terminate at differ-
ent polyadenylation sites could reflect changes in the rates
that these isoforms are generated based on the levels of
polyadenylation factors, or changes in the rates at which
they decay. To understand the relationship between polya-
denylation site selection and transcript fate, we first deter-
mined whether APA with quiescence was associated with a
change in gene expression. Relative expression in quiescent
compared with proliferating fibroblasts was slightly higher
on average for genes that undergo a shift to greater use of
distal polyadenylation sites with quiescence than for genes
that do not undergo APA or use the proximal polyadenyla-
tion site preferentially in quiescence (Fig. 6a, p < 0.001,
Wilcoxon signed-rank test). This finding would be consist-
ent with longer transcripts being more stable.
To better understand the relationship between polya-
denylation site selection and transcript decay rate, we
added actinomycin D to inhibit new transcription in
proliferating or 7dCI fibroblasts, collected RNA over a
timecourse, and performed polyadenylation site-enriched
RNA-Seq to monitor the rate that different gene iso-
forms decayed [62]. The results extend our previous
studies of genome-wide transcript decay rates in prolif-
erating and 7dCI fibroblasts using microarrays [63]. In
two different fibroblast strains (12–1 and 12–3), we
found that isoforms terminating at distal polyadenylation
sites were more stable than isoforms terminating at
proximal polyadenylation sites in quiescent, but not pro-
liferating, fibroblasts (Additional file 12 and Fig. 6b, c).
We identified motifs enriched in the interpolyadenyla-
tion site regions in genes that shift to a longer isoform
with quiescence. Among the RNA-binding proteins that
bind to these motifs, some are induced in quiescent
compared with proliferating cells and would be candi-
dates for stabilizing longer transcripts in quiescent
cells (Additional file 1: Table S5). Our findings indi-
cate that the shift to the use of longer isoforms in
quiescent cells results in an overall stabilization of
transcripts and a modest increase in expression levels.
Therefore, the higher levels of longer isoforms in quies-
cent than proliferating fibroblasts could reflect both a dif-
ference in polyadenylation site selection (influenced by
Table 3 List of genes involved in motility that are altered with CstF64 knockdown
Type of change (analysis) Genesa
Gene expression (DESeq) VIM, WDR1, ACTN1, ACTB, MAPK1, MYH9, BDKRB1, SEMA5A, FN1, IFT43, MYO1B, LMNA, HMGB2, GREM1,
TPM4, DDIT4, IL8, TUBB4B, TUBB, PDCD6
Alternative polyadenylation (Relative
usage of distal site)
MAP4, SP100, DYNC1I2, TBX5, OSBPL8, RBFOX2, BMPR1A, LAMA4, DOCK7, RAP2C, RHOT1, LAMC1, ACTR2,
IQGAP1, RHOT2, APP, LMO4, CERS2, GNA12, EGFR, WASF2, AMFR, SUN1, AMOTL1, STAT3, BSG, EXT1, COL18A1,
NTF3, SIAH1, DPP4, EMP2
aThe genes that changed with quiescence for the same analysis are italicized
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Fig. 5 Changes in polyadenylation site recognition sequences in proximal versus distal polyadenylation sites for genes undergoing APA with
quiescence. a Schematic showing the relative position of the UGUA motif, hexamers, the cleavage site and GU/U-rich motifs. b The frequencies
with which different possible hexamers are present at the proximal or distal polyadenylation sites are shown for genes that have two
polyadenylation sites and shift to the use of more distal polyadenylation sites with quiescence (dark blue). Other hexamers are AAACAU, AAUA
AC, UUAAAG, UUAAAU, UAUAAA, AAUACA, CAUAAA, AAUAUA, GAUAAA, AAUGAA, AAGAAA, ACUAAA, AAUAGA, AAUAAU, AACAAA, AUUACA,
AUUAUA, AACAAG, and AAUAAG. Data are compared with results for genes that use a proximal polyadenylation site or do not change their use
of polyadenylation site with quiescence (light blue). Data are shown for all genes, for genes that undergo UTR APA and for genes that undergo
UR APA. Statistically significant differences were determined by Fisher’s exact test (c) The fraction of genes with a UGUA motif in the region
upstream of the polyadenylation site hexamer is shown. Data are provided for genes that shift to greater use of distal polyadenylation sites in
quiescence (dark blue) and a control set of genes that do not use distal polyadenylaton sites more with quiescence (light blue) (left plots). Data
are also provided for genes that shift to greater use of proximal polyadenylation sites with quiescence (brown) and a control set of genes that do
not shift to greater use of proximal polyadenylation sites (pink) (right plots) Statistically significant differences were determined by two-tailed
Fisher’s exact test. d The fraction of genes with a U-rich motif in the region downstream of the polyadenylation site hexamer are shown. e The
fraction of base pairs 20–40 nts downstream from the polyadenylation site that are Us is shown for genes that shift to use of more distal
polyadenylation sites with quiescence. Statistical significance was determined by Wilcoxon signed-rank test
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levels of polyadenylation factors) and a difference in the
rate at which the shorter and longer transcripts decay in
the two proliferative states.
Cleavage and polyadenylation factors are expressed at
higher levels in wound-healing than quiescent skin in vivo
Wound healing is a situation in which cells are activated
to both proliferate and migrate. We investigated the
levels of cleavage and polyadenylation factors in normal
skin and in dermal excisional wounds in mice. We intro-
duced punch biopsies into the backs of mice and
collected wounded tissue and unwounded control skin
approximately 2 cm from the wound. Immunohisto-
chemistry for the proliferation marker Ki-67 revealed
higher levels of proliferation of a migrating mass of cells
that includes fibroblasts, myofibroblasts, and immune
cells in the skin proximal to the wound compared with
cells in the dermis of control, unwounded skin (Fig. 7)
[64]. Immunostaining for histone H4 as a control re-
vealed similar staining in wounded and control skin as
expected. Immunohistochemistry for CstF-64, CPSF73,
or CFIm25 revealed a higher fraction of cells with
Fig. 6 Higher expression and increased stability for genes that shift to greater reliance on distal polyadenylation sites in quiescence. a For two
different fibroblast lines (12–1 and 12–3), the log2(7dCI counts/Proliferating counts) is plotted for genes that shift to increased use of more distal
polyadenylation sites with quiescence and a control group that does not shift to more distal site use. Boxes indicate 25 to 75% ranges and
whiskers indicate minimum and maximum values. Statistical significance was determined with Wilcoxon signed-rank test. The ratio of expression
level in 7dCI versus P was higher for genes that shift to more distal polyadenylation site use with quiescence for both 12–1 and 12–3 fibroblasts.
b Isoform-specific transcript decay half-lives were determined for 12–1 and 12–3 strains of fibroblasts in proliferating and quiescent conditions.
Box plots show the range of half-lives for isoforms that terminate at proximal polyadenylation sites and isoforms that terminate at more distal
polyadenylation sites in proliferating and quiescent conditions. Long isoforms are significantly more stable in quiescent but not proliferating
states in 12–1 and 12–3 fibroblasts. Statistically significant differences were determined by Wilcoxon signed-rank test. c Density plots of half-lives
for isoforms that terminate at proximal or distal polyadenylation sites in proliferating and quiescent fibroblasts from strains 12–1 and 12–3
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positive nuclei in the region surrounding the wounded
skin for all three factors than in control, unwounded
skin (Fig. 7). This analysis revealed that the shift toward
higher levels of cleavage and polyadenylation factors in
proliferating fibroblasts in culture also occurs in the mi-
gratory, proliferating cells that heal wounds in vivo.
CstF-64 knockdown reduces fibroblast migration
Based on the consistency with which we observed
changes in the mRNA processing and expression of
genes important for cell motility in proliferating versus
quiescent fibroblasts (Table 1), we hypothesized that
changes in mRNA processing associated with the transi-
tion between proliferation and quiescence are also im-
portant for the closely linked process of cell migration.
First we tested the association between proliferation and
migration. We generated fibroblasts that were proliferat-
ing, induced into quiescence by 7dSS, or restimulated
after 7dSS by re-addition of medium with serum. We
monitored the rate at which fibroblasts in each
Fig. 7 Cleavage and polyadenylation factors are expressed at higher levels in fibroblasts near a wound than in fibroblasts of healthy skin. Mouse
skin was collected 5 days after introduction of a punch biopsy. Normal mouse skin was collected 2 cm away from the wound. Samples were
stained with immunohistochemistry for proliferation marker Ki-67, histone H4 as a control, or alternative polyadenylation and cleavage factors
CstF-64, CPSF73 or CFIm25 (brown). Samples analyzed with immunohistochemistry were counterstained with hematoxylin (blue nuclei). Individual
cells at different positions from the wounds were assigned positive or negative staining and the percentages are shown. Ki-67 does not label all
dividing cells, and likely underestimates the fraction of cells that are actively cycling [122]. Levels of all three cleavage and polyadenylation factors
were higher in the fibroblasts, myofibroblasts and immune cells proximal to a wound than in the fibroblast-rich dermal areas of healthy skin
distal to the wound
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condition migrated into a denuded area on a tissue cul-
ture plate with real-time imaging (Fig. 8a). Migration
was quantified as the ratio of cell concentration in the
denuded area compared to the cell concentration in the
non-denuded area, thus normalizing for possible differ-
ences in proliferation rate. We discovered that the prolif-
erating and restimulated fibroblasts migrated into the
denuded area more rapidly than the serum-starved fibro-
blasts (Fig. 8b).
We observed changes in the transcript and protein
levels of cleavage and polyadenylation factors as fibro-
blasts transition between proliferation and quiescence.
To test whether levels of cleavage and polyadenylation
factors change in fibroblasts induced to migrate into a
denuded area, we introduced denuded areas into cul-
tures of fibroblasts and performed immunofluorescence
to monitor the levels of cleavage and polyadenylation
factors. CstF-64 and CPSF73 levels were significantly
higher in the cells that had migrated into the denuded
area than cells that had not migrated, while no signifi-
cant change was observed for CFIm25 (Additional file 1:
Figure S9). We then tested the importance of alternative
polyadenylation factors for fibroblast motility. We gener-
ated knockdown fibroblasts with control siRNAs or siR-
NAs against cleavage and polyadenylation factors, and
monitored the rate of migration. Knockdown of CstF-64
with any of three different siRNAs (Fig. 8c) resulted in
reduced migration into the denuded area (Fig. 8d).
CstF-64 siRNA #1 had the strongest effect on CstF-64
levels and resulted in the most significant reduction in
migration. Knockdown of CPSF73 (Fig. 8c) resulted in
slower migration, but the difference was not statistically
significant (Fig. 8d). Knockdown of CFIm25 (Fig. 8c) did
not affect migration rate (Fig. 8d). Thus, CstF-64 is
induced in migrating cells, and knockdown of CstF-64
resulted in APA changes and downregulation of genes
that overlap with those that occur with quiescence, in-
cluding genes associated with cell migration (Table 3).
These findings are consistent with our observation here
that knockdown of CstF-64 simulates the reduced mi-
gration observed for quiescent fibroblasts.
Knockdown of cleavage and polyadenylation factors
reduces migration of triple negative breast cancer cells
To determine the generality of our findings for different
types of cells, we tested the effects of siRNAs targeting
CstF-64, CPSF73 or CFIm25 on the migration of triple
negative breast cancer cells (Additional file 1: Figure S3).
Triple negative breast cancer is a highly aggressive breast
cancer subtype characterized by a lack of hormonal re-
ceptors and an absence of HER2 amplification [65].
Knockdown of CstF-64 or CPSF73 resulted in signifi-
cantly reduced migration of triple negative breast cancer
cells (Fig. 8e). The triple negative breast cancer cells
were even more sensitive to altered polyadenylation site
selection than the fibroblasts, which may reflect the in-
creased reliance of cancer cells on proximal polyadenyla-
tion sites [20, 45, 46, 66]. Our results demonstrate that
the selection of polyadenylation sites can affect the mi-
gratory capacity of cancer cells as well as fibroblasts in
wound healing (Fig. 8f ).
Discussion
While we and others have shown that the transition to
quiescence is associated with widespread changes in
gene expression [9–11], and others have previously
shown changes in the selection of polyadenylation sites
with quiescence [21], we sought here to better under-
stand the relationship between quiescence and alterna-
tive polyadenylation. Gene expression analysis of
RNA-Seq data revealed that genes involved in mRNA
processing (splicing and polyadenylation) are downregu-
lated as fibroblasts enter quiescence (Fig. 1c, d). These
findings suggested to us that processing of pre-mRNA
transcripts may be different in quiescent compared with
proliferating cells, and that these changes may contrib-
ute to changes in transcript abundance and the func-
tional attributes of proliferating versus quiescent
fibroblasts. We further discovered through differential
exon analysis of RNA-Seq data that hundreds of genes
exhibit changes in isoform expression during the transi-
tion to quiescence. Quiescent fibroblasts expressed lower
levels of some auxiliary splicing factors (Fig. 2b) and
were more likely to include exons and retain introns
than proliferating fibroblasts (Fig. 2a), demonstrating
cell-cycle state-dependent changes in splicing and intron
retention [38]. Introns that were retained tended to have
splicing motifs that varied from the consensus sequence,
especially for the polypyrimidine tract adjacent to 3′
splice sites in the proliferating state (Fig. 2c), potentially
reducing the effectiveness of splicing factors or associ-
ated RNA binding proteins. Our results are consistent
with a model in which quiescence is associated not with
a complete shut-down of mRNA processing events, but
rather with a shift in the processing of specific tran-
scripts such that, in addition to changes in gene expres-
sion, an alternative set of exons and isoforms are present
in fibroblasts that are proliferating versus quiescent.
Genes involved in cell motility were among those dem-
onstrating consistent changes in splicing in proliferating
versus quiescent cells (Table 1).
Among the changes in isoform use that we observed,
the most prominent effect was a change in the selection
of polyadenylation sites in proliferating versus quiescent
fibroblasts. In response to quiescence induced by contact
inhibition, 714 genes exhibited a change in polyadenyla-
tion site selection, and in 88% of instances, alternative
polyadenylation site use resulted in a lengthening of
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Fig. 8 Knockdown of APA factors results in reduced migration. a Example of Incucyte migration assay. Bright-field images from an assay monitoring the rate of
migration into a denuded area (marked by a double-arrow) performed with Incucyte real-time imaging are shown. b Proliferating fibroblasts migrate more
rapidly into a denuded area than quiescent fibroblasts. Fibroblasts were sampled in proliferating conditions, 7dSS conditions (7dSS), or after 7dSS followed by
serum restimulation (7dSS-R). Fibroblasts were plated into 96-well plates and a portion of the well was denuded of cells. Plates were analyzed with an Incucyte
real-time imaging instrument and the associated software to monitor the rate at which fibroblasts migrated into the denuded area. The ratio of cell density in
the denunded area to the non-denuded area (relative wound density) over a time-course is plotted. Six wells were monitored for each condition and data
represent mean and standard deviation. Proliferating versus 7dSS samples (p value < 0.001, repeated measures two-way ANOVA with Dunnett’s multiple
comparison test), proliferating versus 7dSS-restimulated samples (p value < 0.001), and 7dSS versus 7dSS-R (p value < 0.001) were statistically significantly
different. c Immunoblots demonstrating knockdown of the targeted cleavage and polyadenylation factor by siRNAs in fibroblasts. The percent knockdown of
protein level is also shown. d Knockdown of CstF-64 reduces fibroblast migration. Fibroblasts were transfected with a control siRNA or an siRNA against CFIm25,
CstF-64, or CPSF73. CstF-64-knockdown fibroblasts exhibited reduced migration into a denuded area than control fibroblasts (CstF64.1 p value = 0.0013). Two
additional siRNAs against CstF-64 (CstF64.2 and CstF64.3) reduced migration compared with a matched control siRNA as well (CstF64.2 p value = 0.0021, CstF-
64.3 p value = 0.0384). Six replicates were performed for each condition. e Knockdown of CstF-64 or CPSF73 reduced migration of triple negative breast cancer
cells. Triple negative breast cancer cell line MDA-MB-231 was transfected with a control siRNA or an siRNA against CstF-64, CPSF73 or CFIm25. Migration into a
denuded area on the plate was monitored with an Incucyte instrument. Knockdown of CstF-64 or CPSF73 resulted in reduced migration (CstF64 p value =
0.0002, CPSF73 p value = 0.0013). For all conditions, the number of replicates for each condition was 6. f Schematic diagram showing elevated cleavage and
polyadenylation factors in fibroblasts in the wound-healing environment. Increased expression of CstF-64, CPSF73, and CFIm25 in fibroblasts in wounds is
expected to result in increased use of proximal polyadenylation sites and may promote fibroblast migration to the wound
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transcripts in quiescent compared with proliferating cells
(Fig. 3c). These findings are consistent with previous
studies that revealed that 3′ UTRs are shorter in more
rapidly proliferating cells [18, 21], stem cells [67], and
cells and tissues derived from tumors [20, 46, 68], and
longer in cells that divide less frequently such as differ-
entiated tissues [13, 15, 67]. We found that 3′ UTR
lengthening reverses when quiescent cells re-enter the
cell cycle (Fig. 3b), demonstrating that these changes can
be reversed based on proliferative state.
To better understand the basis for the changes in polya-
denylation site selection in proliferating versus quiescent
fibroblasts, we monitored the levels of polyadenylation
factors in proliferating and quiescent cells. Transition to
quiescence was associated with lower levels of cleavage
and polyadenylation factors CstF-64, CFIm25, and
CPSF73 (Fig. 3d). Knockdown of each these three factors
resulted in changes in polyadenylation site use that over-
lapped significantly with the changes that occurred with
quiescence (Fig. 4b and Additional file 1: Figure S5A and
B). There were also changes in gene expression as a result
of knockdown of specific factors, especially CstF-64. These
gene expression changes overlapped with changes in gene
expression that occur with quiescence (Fig. 4c and Add-
itional file 1: Figure S5C).
To further understand the contribution of different
cleavage and polyadenylation complexes to the shift in
polyadenylation site selection with quiescence, we moni-
tored the presence of their recognition sites. For genes
that use more distal upstream region polyadenylation
sites with quiescence, the proximal hexamer was much
more likely to match the canonical hexamer, and very
unlikely to be absent (Fig. 5b). A similar shift was ob-
served with CPSF73 knockdown (Additional file 1: Fig-
ure S6A). This is consistent with reduced expression of
CPSF73, and reduced use of upstream region proximal
polyadenylation sites, as a factor contributing to the
lengthening of transcripts with quiescence. A role for re-
duced CstF-64 levels in quiescent cells promoting the
shift to more distal polyadenylation sites is supported by
the finding that the sequence between 20 and 40 bps
downstream of the proximal polyadenylation site in-
cluded more Us on average and more Gs and Us on
average, for genes that use more distal polyadenylation
sites with quiescence (Fig. 5e). Taken together, the
results support the importance of reduced levels of
cleavage and polyadenylation factors with quiescence,
with the polyadenylation pattern for specific sequences
determined in part by the presence or absence of bind-
ing factors for the reduced factors.
Some previous studies have reported that shorter tran-
scripts generated by alternative polyadenylation tend to
be expressed at higher levels than the corresponding
longer isoform [20, 46, 69, 70], while other studies have
found little effect of alternative polyadenylation on tran-
script levels, transcript stability or protein abundance
[71, 72]. Additional studies have found that shorter tran-
scripts can be more or less stable [71, 73], and two de-
tailed analyses in yeast showed clear examples of
stability elements in 3′ UTRs that make longer isoforms
more stable than shorter isoforms [74, 75]. In our study,
we observed that genes with longer 3′ UTRs during qui-
escence, on average, exhibited a small but significant in-
crease in expression level during quiescence compared
to proliferating cells (Fig. 6a). Further, isoforms are more
stable when distal rather than proximal polyadenylation
sites are used in the quiescent state, but decay rates are
similar when proximal or distal sites are used in the pro-
liferating state (Fig. 6b, c). The findings are consistent
with induction of an RNA-binding proteins in quiescent
cells that bind to motifs present in the region between
the polyadenylation sites and limit transcript degradation
when the cells are quiescent. There are multiple motifs
recognized by RNA-binding proteins in this
inter-polyadenylation site region, and some of the factors
that recognize these motifs are expressed at higher levels
in quiescent than proliferating fibroblasts
(Additional file 3). The findings are also consistent with
the retention of longer transcripts in ribonucleoprotein
storage granules or other structures in quiescent cells
[76]. These changes could contribute to the higher gene
expression levels of transcripts undergoing transcript
lengthening in quiescence (Fig. 6a).
In many [20], but not all [77], studies, cancerous tissue
and cancer cell lines were found to be more likely to ex-
press transcripts that terminate at proximal than distal
polyadenylation sites, consistent with our observations in
proliferating fibroblasts. Different polyadenylation factors
have been found to have distinct effects on APA. Down-
regulation of CFIm25 repressed proximal polyadenylation
site use (Additional file 1: Figure S4C) consistent with pre-
vious reports [45, 54]. Depletion of CFIm25 has been
found to enhance the tumorigenic properties of glioblast-
oma cells [45], while overexpression of CFIm25 reduced
tumor growth [45]. Shortening of 3′ UTRs has been asso-
ciated with poor prognosis in breast and lung cancer [78].
Further, in an analysis of multiple tumor datasets depos-
ited in The Cancer Genome Atlas, expression of CstF-64
correlated most closely with shortening of transcripts,
with CPSF73 showing the next best correlation among the
factors investigated [46]. Expression of shorter 3′ UTRs
was an important predictor of patient outcome even be-
yond established clinical attributes [46]. In another study,
CstF-64 expression was found to be associated with poor
prognosis in lung cancer and its overexpression increased
lung cancer cell proliferation and invasion [79]. In our
dataset, cyclin D1 was the most strongly downregulated
gene when CstF-64 was knocked down (Additional file 11),
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raising the possibility that CstF-64 levels modulate polya-
denylation site selection and cyclin levels. Taken together
with our data demonstrating that downregulation of
CstF-64 in triple negative breast cancer cells reduces their
migration (Fig. 8e), the data as a whole suggest that
CstF-64-mediated APA may play an important role in
regulating polyadenylation site selection, gene expression,
cancer cell migration, metastasis, and patient outcome.
Fibroblasts transition from quiescence to proliferation
and become more migratory in the context of wound
healing. Some previous studies have supported a role for
mRNA processing in wound healing [80–83]. By investi-
gating the wound healing response in mice, we found that
the levels of polyadenylation factors CstF-64, CFIm25, and
CPSF73 were significantly higher in the area adjacent to
the wound than distal to the wound (Fig. 7), similar to our
finding that these factors are expressed at higher levels in
proliferating than quiescent fibroblasts in culture (Fig. 3d).
The results support a possible role for alternative polyade-
nylation in the proliferative and migratory changes that
occur in the wound healing process.
Previous studies have identified mechanistic links
between fibroblast proliferation and migration. Mitogen
binding to receptor tyrosine kinases can activate focal ad-
hesion kinase (FAK) and thereby stabilize focal adhesions
[84, 85]. Activation of receptor tyrosine kinases can also
recruit WASp [86], which promotes the formation of
branched actin filaments that promote cell migration. The
anti-proliferative cyclin-dependent kinase inhibitor
p27Kip1 binds to and inhibits the activity of RhoA GTPase
[87], an important regulator of actin dynamics and adhe-
sion, spreading and migration [88]. Our findings that
downregulation of APA factors, as occurs in response to
antiproliferative signals via E2F transcription factors [21],
reduces the capacity of fibroblasts to migrate into a de-
nuded area, represents another mechanism linking fibro-
blast proliferation to migration through APA. We found
that CstF-64 is induced in migrating cells, and knockdown
of CstF-64 resulted in changes in polyadenylation site
selection, altered expression of several migration genes
(Table 3), and reduced cell migration (Fig. 8d). Among the
genes expressed at lower levels with CstF-64 knockdown
are beta actin, α-actinin, and myosin 1b. Our findings sup-
port a model in which changes in the selection of polyade-
nylation sites or changes in gene expression mediated by
the levels of alternative polyadenylation factors play an im-
portant role in critical cell functions including migration.
In a separate manuscript, we investigate in more detail the
effects of isoform changes in one particular gene, RECK
(included in Table 1 under UR-APA), on migration [89].
Taken together, our data and the data emerging from
other laboratories, underscore the importance of CstF-64
as an important regulator of cellular functions, including
migration, in multiple cellular contexts.
Conclusions
Our work demonstrates that, in addition to changes in
gene expression, the shift from a proliferating to a quies-
cent state is associated with changes in intron and exon
inclusion and with the selection of polyadenylation sites.
Overall, quiescent cells tend to retain introns and ex-
press longer transcripts that are present at higher levels
and are more stable. Cleavage and polyadenylation factor
CstF-64 is more abundant in proliferating fibroblasts in
culture and in fibroblasts near a denuded area or a
wound in mice. Knockdown of CstF-64 recapitulates
changes in isoform use and gene expression in quiescent
cells, and results in reduced cell migration in fibroblasts
and cancer cells. Fibroblasts are often induced to prolif-
erate and migrate in similar situations, and our data in-
dicate that changes in the levels of CstF-64 can serve as
a link between proliferative cues and migratory capacity.
Methods
Cell culture
Human foreskin fibroblasts were isolated from human
skin obtained from the National Disease Research Inter-
change (NDRI) as described previously [24, 90]. Cells were
seeded at 5 × 105 cells per 10 cm dish for each cell cycle
state and grown in Dulbecco’s modified Eagle medium
(DMEM) (Life Technologies, Grand Island, NY) supple-
mented with 10% fetal bovine serum (FBS) (Atlanta Bio-
logicals, Flowery Branch, GA and Corning, Thermo Fisher
Scientific, Waltham, MA) at 37 °C in a 5% CO2 incubator.
Detailed procedures for culturing proliferating and quies-
cent fibroblasts are described in [91]. Briefly, proliferating
fibroblasts were collected for analysis 2 days after plating
(60–80% confluent). 7dCI fibroblasts were collected 7 days
after plating, or at an equivalent density, while 7dSS fibro-
blasts were seeded in full serum medium (10% FBS in
DMEM), changed to reduced serum medium (0.1% FBS in
DMEM), and collected 7 days after adding the reduced
serum medium. Medium was changed every 2 days for
both 7dCI and 7dSS fibroblasts. Restimulated samples
were prepared by first performing the relevant quiescence
arrest and readding the limiting factor. Restimulated fibro-
blasts were monitored with Incucyte migration assays or
collected 24 or 48 h later for real-time PCR analysis. The
triple negative breast cancer cell line MDA-MB-231 cell
line (generous gift of the Banerjee and Christofk laborator-
ies) was grown in 10% FBS in DMEM.
RNA isolation for RNA-Seq and microarray analysis
RNA-Seq was performed on three biological replicates
of fibroblasts isolated from two different donors, 12–1
and 10–5. Medium was aspirated from tissue culture
plates of fibroblasts, and the attached cells were washed
with 5 ml of PBS. Attached fibroblasts were lysed into
1 mL of Trizol reagent (Life Technologies, Carlsbad,
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CA) per 10 cm plate for 5 min. RNA was isolated from
Trizol lysates as previously described [92, 93]. RNA con-
centrations were determined using a Nanodrop Spectro-
photometer (Thermo Fisher Scientific Inc., Waltham,
MA). RNA quality was verified on a Bioanalyzer 2100
(Agilent Technologies, Santa Clara, CA) using reagents
from the RNA Nano 6000 kit (Agilent Technologies).
RNA-Seq analysis
cDNA libraries were constructed using the Illumina Tru-
Seq mRNA sample preparation kit (Illumina Inc., San
Diego, CA) according to the manufacturer’s instructions
for revision A of the protocol (Illumina Part #15008136).
The low-input protocol was followed for all samples, and
1 to 10 μg of total RNA input was used per library
(unstranded). Single-end 140 bp reads were generated on
an Illumina HiSeq 2000 Instrument. Reads with Illumina
(PHRED-based) quality scores above 10 (90% accuracy)
were mapped to the hg19/GRCh37 build of the human
genome using the TopHat (version 2.0.9) genome align-
ment algorithm [94, 95]. The bowtie indices for human
were obtained from the bowtie website: http://bowtie-bio.-
sourceforge.net/tutorial.shtml. The standard workflow for
Tophat alignment was followed as described here: https://
ccb.jhu.edu/software/tophat/manual.shtml.
The default parameters for alignment as described in
the Tophat manual were used. Standard DESeq (version
1.22.0) workflow [96] (https://bioconductor.org/packages/
release/bioc/html/DESeq.html) was used to convert the
output of TopHat (BAM files) to a file format with gene
identifiers (UCSC gene annotation, GRCh37/hg19 assem-
bly, date of access June, 2013) and read counts normalized
for sequencing depth across the different biological sam-
ples and cell cycle conditions. Information about bio-
logical replicates was provided as input for variance
calculations to determine differential expression among
proliferating and 7dCI conditions in DESeq. To identify
differentially expressed genes, the log2 (7dCI read count/
proliferating read count) was used to compare expression
differences between the two states. Genes with differences
in read counts between conditions (proliferation versus
7dCI), and low variance in expression within the three
biological replicates of each condition, were called signifi-
cant by DESeq after multiple hypothesis correction (FDR
< 5%) [97]. Heat maps were generated using the heatmap2
function of gplots package (2.12.1) (https://cran.r-projec-
t.org/web/packages/gplots/index.html) implemented in
the R programming language [98, 99].
Gene set enrichment analysis
For RNA-Seq data, gene sets with significantly differ-
ent expression between proliferating and quiescent fi-
broblasts were identified using a Wilcoxon rank-sum
test comparing the log fold-change estimates of genes
within each set to genes not within the set [100].
Graphics were created using the GSEMA package
implemented in R [101].
Differential isoform analysis
To determine differential isoform use between proliferat-
ing and quiescent fibroblasts, the standard DEXSeq (ver-
sion 1.14.2) workflow (https://bioconductor.org/
packages/release/bioc/html/DEXSeq.html) [29] was
followed. BAM files generated by aligning RNA-Seq
reads to the human genome (hg19/GRCh37 build) were
converted to gene-normalized read count files using
exons as the identifiers. The Ensembl gene annotation
(GRCh37 assembly) file was obtained from https://
ccb.jhu.edu/software/tophat/igenomes.shtml. Differential
exon expression was determined across the three bio-
logical replicates. Genes with significant differences in
expression for specific exons (adjusted p value < 0.05)
between proliferating and 7dCI conditions were used for
further analysis.
Microarray gene expression analysis
An aliquot of the same total RNA that was analyzed by
RNA-Seq was also analyzed by microarray. Total RNA
was reverse-transcribed into cDNA and fluorescently la-
beled with Cyanine 3-CTP (7dCI samples) or Cyanine
5-CTP (proliferating samples) with the Quick Amp Label-
ing Kit for Microarray Analysis (Agilent Technologies,
Santa Clara, CA) following the manufacturer’s protocol.
cRNA samples that passed yield and labeling standards
were fragmented, and proliferating and quiescent samples
were hybridized to two-color Human gene expression 4 ×
44 K microarrays (Agilent Technologies) for 17 h at 65 °C
in an oven rotating the arrays at 10 rotations per minute.
Fluorescence intensities were detected using the Genepix
scanner (Agilent Technologies) and probe identities were
determined using Agilent’s feature extractor version 11.5.
Probes detected over background fluorescence thresholds
were used in subsequent gene expression analyses to
calculate log2 (7dCIintensity/Pintensity).
Differential splicing analysis
RNA-Seq reads (fastq files) from three replicates of
proliferating fibroblasts and three replicates of 7dCI fi-
broblasts were analyzed with the rMATS algorithm re-
lease 3.2.1 (http://rnaseq-mats.sourceforge.net/rmats
3.2.1.beta/) [31–33] using Ensembl gene annotation
(GRCh37 assembly). Reads were trimmed to a length of
100 bps for analysis using the Trim Fastq tool provided as
part of rMATS package. Standard workflow for rMATS
(default parameters as described in: http://rnaseq-mats.-
sourceforge.net/rmats3.2.1.beta/user_guide.htm) was used
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for the splicing analysis using the reads that cover the spli-
cing junctions and target regions. Alternative splicing
events with an FDR of < 0.05 were considered statistically
significant.
Polyadenylation site-enriched RNA-Seq
We performed polyadenylation site-enriched RNA-Seq
with two methodologies (Gnomegen [89] and Nextera).
Here we describe the second approach, Nextera. For
polyadenylation site-enriched RNA-Seq, two different
primary dermal fibroblasts, 12–1 and 12–3, were used as
biological replicates. Proliferating, 7dCI, and siRNA-
treated fibroblasts were lysed by adding 1 ml of Trizol
per 10 cm plate and incubating the plate for 5 min at
room temperature. RNA was isolated from the cell
lysates using the Direct-zol™ RNA MiniPrep Plus kit
(Zymo Research, Irvine CA) by following the manufac-
turer’s instructions. The concentration of RNA was mea-
sured using Nanodrop 2000c (Thermo Fisher Scientific).
cDNA libraries containing fragments enriched for
3’UTR ends were created with the Nextera kit using the
Smart-seq2 cDNA amplification method as described in
[102]. Common forward primers were used for all sam-
ples; reverse primers with a unique barcode sequence (i5
indices) were specific for each sample. The size distribu-
tion of the cDNA library was confirmed using a High
Sensitivity DNA chip (Agilent Technologies) on a Bioa-
nalyzer 2100 Instrument (Agilent Technologies). Librar-
ies with a uniform size distribution between 150 and
1000 bp were subjected to gel size selection to enrich for
180–280 bp sized fragments. The concentration of the
final library was measured on a qubit fluorometer
(Thermo Fisher Scientific). Single-end 150 bp reads were
generated on an Illumina HiSeq 2500 Instrument. The
sequencing reaction was run for 150 cycles.
Polyadenylation site-enriched RNA-Seq analysis
Reads from polyadenylation site-enriched cDNA libraries
were demultiplexed followed by removal of adapter and
polyA tail sequences. Trimmed reads were aligned to the
human genome (hg19/GRCh37 build) using TopHat
(version 2.0.14) [94] using default parameters. Aligned
reads were assigned to a polyadenylation site based on
annotations in the Poly(A)site atlas (version:r1.0(hg19)
by Gruber et al. [103] using the Perl script provided
(http://www.polyasite.unibas.ch/). Only the polyadenyla-
tion sites annotated as TE (terminal exon), EX (any
other exon except the terminal one), or IN (any intron),
and with at least 10 counts across all the samples, were
included for analysis. For genes containing two polyade-
nylation sites, the relative use of the distal polyadenyla-
tion site (RUD) [13, 18] was determined as distal
polyadenylation counts/total read counts (distal plus
proximal counts). The RUD values for two biological
replicates were averaged to determine the RUD value of
a gene. Changes in alternative polyadenylation between
the two conditions were significant if the RUD difference
between them was greater than 0.05. For genes with
more than two polyadenylation sites, a parameter called
relative site usage (counts for a polyadenylation site di-
vided by total counts for all the polyadenylation sites)
was calculated for all the polyadenylation sites of a gene.
To perform differential expression analysis, counts from
all the polyadenylation sites of a gene were combined
and the combined counts for all the genes for two differ-
ent conditions were subjected to DESeq2 (version 1.18)
analysis [96, 104] using standard parameters (Ensembl
annotation, GRCh37 assembly).
Transcript decay rate measurements
Detailed protocols for cell culture and actinomycin D
treatment are described in [63, 105]. Briefly, to monitor
transcript decay rates, proliferating and 7dCI fibroblasts
were treated with 15 μg/ml actinomycin D (Sigma-Al-
drich, Inc., St. Louis, MO). Cells were washed with PBS
and cell lysates were collected using Trizol reagent (Life
Technologies) at 0, 120, 240, and 480 min after addition
of actinomycin D. RNA was isolated from Trizol lysates
using the Direct-zol™ RNA MiniPrep Plus kit (Zymo Re-
search). cDNA library preparation, sequencing, and pro-
cessing of reads were performed as described for
polyadenylation-site enriched RNA-Seq.
Decay rate calculations
For comparisons of decay rates under different condi-
tions, only the genes with two polyadenylation sites
(proximal and distal) in the 3′ UTR were used for ana-
lysis. Further, only transcripts with a minimum of 10
counts at t = 0 were used. For each polyadenylation site,
the counts at four time points (0, 2, 4, and 8 h) were
log-transformed and fit to a linear decay model ([63,
105]) using the least squares method to determine a fit-
ting parameter (R2) and to obtain decay constants. Only
the polyadenylation sites with R2 value greater than 0.6
were used. The decay constants (k) were converted to
half-lives (ln2/k) for isoform-specific analysis.
Motif analysis
For all of the transcripts that undergo APA with quies-
cence and had two detectable polyadenylation sites, se-
quences (in FASTA format) were obtained from the
UCSC Genome Browser (Table browser tool, hg19/
GRCh37 build, accessed on March 2018) that include
the polyadenylation site itself, 100 nts upstream (for
UGUA motif analysis), and the region 20 to 40 nt down-
stream (for U-rich and UG-rich motif analysis) of the
polyadenylation site. For hexamer analysis, the hexamer
associated with each of the polyadenylation sites was
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obtained from Poly(A)site atlas annotations (Homo
sapiens-version:r1.0(hg19)) by Gruber et al. (http://
www.polyasite.unibas.ch/) [103]. For sites associated
with more than one hexamer, we chose the hexamer
with the highest signal strength as determined by Gruber
et al. For UGUA analysis, FIMO (v4.12.0) [106] motif
analysis tool of the MEME suite was used with p value set
to 1 to return matches to all of the UGUA motifs.
Post-processing of the FIMO results was used to check for
exact matches. For RBP motif analysis, primary sequences
(in FASTA format) from the alternate region (region be-
tween proximal and distal sites in the 3′ UTR) for genes
that become longer (distal polyadenylation site use) with
quiescence were extracted using the Table browser tool of
the UCSC Genome Browser (hg19/GRCh37 build,
accessed on March 2018). To generate a background data-
set, all the sequences from alternate regions of genes that
use more proximal sites with quiescence and genes with
no change in polyadenylation site use with quiescence
were used. RBP motifs enriched in primary sequences in
comparison with background sequences were obtained
using the analysis of motif enrichment (AME, v4.12.0)
motif enrichment tool [107] of the MEME suite. The RNA
motifs from Ray2013 Homo sapiens motif database [108]
were used for enrichment testing. Only the RBP motifs
enriched in both 12–1 and 12–3 biological replicates were
considered. For U-rich and UG-rich analysis, the se-
quences of the regions encompassing 20 to 40 nt down-
stream of the polyadenylation site for each gene were
extracted for all genes with two polyadenylation sites using
the Table browser tool of the UCSC genome browser
(hg19/GRCh37 build, accessed on March 2018). The
U-rich sequences in this region have been shown to be the
preferred binding sites of CstF64 using crosslinking immu-
noprecipitation (CLIP)-Seq analysis [109]. Percent U was
calculated by determining the fraction of Us present in this
region. Percent UG was calculated by determining the
sum of the fractions of Us and Gs present in this region.
For analysis of 4-mer UUUU sequence [110], the presence
or absence of a UUUU motif was determined in this
region.
Splicing site analysis
Nucleotide sequences were extracted for the 5′ and 3′
splice sites for 139,180 constitutive exons from HEXE-
vent online database [111] and for the introns called dif-
ferentially retained (FDR < 0.05) by rMATS in
proliferating or quiescent fibroblasts (Additional file 4).
For analyzing 5′ and 3′ splice sites, motifs of 9 bases (3
bases in the exon and 6 bases in the intron) and 23 bases
(20 bases in the intron and 3 bases in the exon), respect-
ively, were used. A position weight matrix was generated
from constitutive exon 5′ and 3′ sequences using scripts
written in the R programming language [112, 113].
Based on this position weight matrix, the probability of
each sequence was determined for each sequence in the
list of constitutive exons, introns retained in proliferat-
ing conditions and introns retained in quiescent condi-
tions. Statistical significances of the groups of
probabilities were determined with ANOVA with
Tukey’s multiple comparison test. Sequence logos were
generated from the position weight matrix using the R
programming language (seqLogo package, https://bio-
conductor.org/packages/release/bioc/html/seqLogo.html)
[114].
Antibodies for immunoblotting
Antibodies against tubulin (T6074) and CFIm25
(AV40695-100UG, 1:800 dilution) were obtained from
Sigma-Aldrich, Inc. (Saint Louis, MO). An antibody
against CstF-64 (sc-28201, 1:200) was purchased from
Santa Cruz Biotechnology, Inc. (Dallas, TX). An anti-
body against U1-70K (06-1297, 1:2000) was purchased
from EMD Millipore (Billerica, MA). Antibodies against
CPSF73 (A301-090A-T), U2AF65 (A303-665A-T), FUS
(A300-292A-T), and RNA Polymerase II Phospho S5
(A304-208A-T) were purchased from Bethyl Laborator-
ies (Montgomery, TX) and used at 1:1000 dilution.
Immunoblotting
Immunoblotting was performed using a standard proto-
col similar to that described previously [7]. Briefly, cells
were lysed using mammalian protein extraction reagent
(MPER) (Thermo Fisher Scientific Inc., Waltham, MA)
containing protease and phosphatase inhibitors (Roche
Applied Science, Indianapolis, IN) according to the man-
ufacturer’s instructions (Thermo Fisher Scientific Inc.).
Total protein concentrations in collected lysates were
measured using Pierce™ BCA protein assay kit (Thermo
Fisher Scientific Inc.). Samples were run on SDS PAGE
gels and transferred to polyvinylidene difluoride
Immobilon-P membranes (EMD Millipore, Billerica,
MA). Membranes were blocked with 5% BSA in
phosphate-buffered saline-Tween. Immunodetection was
performed using primary and HRP-conjugated second-
ary antibodies based on standard protocols.
Mouse wounding assays
All experiments were approved by the UCLA Office for
Animal Research, protocol number 2015–033. C57/BL6
mice were provided housing and husbandry in accordance
with Institutional Animal Care and Use Committee
approved protocols. Mice that were approximately 8–
10 weeks of age were anesthetized, shaved, and provided
with analgesia. We introduced one full thickness dermal
punch biopsy of 3.5 mm on each mouse’s upper back. On
day 5 after wounding, the mouse was 83.6% healed. Mice
were euthanized with CO2 followed by cervical
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dislocation. We excised the wound bed en bloc with the
surrounding soft tissue and at least 0.5 cm of normal tis-
sue surrounding the incision. We also collected normal
skin from the same mice for comparison. Skin and
wounds were fixed in formalin and paraffin-embedded.
Slides were cut from paraffin blocks for
immunohistochemistry.
Immunohistochemistry
Tissue slices (4 μm) from paraffin-embedded blocks con-
taining wounds were de-paraffinized and rehydrated with
a graded series of alcohols. Slides were subjected to
heat-induced antigen retrieval with pH 6.0 citrate buffer.
Slides were treated with primary antibodies against Ki-67
(Abcam, catalog no. ab16667, dilution 1:150), histone H4
(EMD Millipore, 05-858, 1:2000), CstF-64 (Bethyl Labora-
tories, IHC-00221, 1:1000), CPSF73 (Bethyl, A301-090A,
1:200) or CFIm25 (Sigma, AV40695, 1:200), followed by
EnVision+ HRP-conjugated secondary antibody (Dako)
and DAB chromogen (Roche) visualization. Slides were
counterstained with hematoxylin and imaged with a Zeiss
AXIO Imager.D2 microscope.
Immunofluorescence
A monolayer of contact-inhibited fibroblasts in a 35-mm
dish with a glass bottom (MatTek Corporation, Ashland,
MA) was scratched (crosswise) using a sterile 1 ml pip-
ette tip to create a region free of cells (wound area). The
cells were then gently washed two times using complete
medium to remove the non-adherent cells generated
during scratching. After 24 h, the cells were fixed with
4% paraformaldehyde (Santa Cruz Biotechnology Inc.,
Dallas, TX) in PBS for 15 min at room temperature and
then washed three times with ice-cold PBS. The cell
permeabilization was performed using 0.25% Triton
X-100 (Thermo Fisher Scientific, NJ) followed by wash-
ing the cells three times with PBS. The cells were
blocked using blocking solution (1% bovine serum
album (BSA) in PBS containing 0.2% Tween (Thermo
Fisher Scientific) at room temperature for 30 min. After
blocking, the cells were incubated with primary anti-
bodies (CstF64, CPSF73, or CFIm25) in blocking solu-
tion (1:100 dilution) at 4 °C in a humidified chamber
overnight. The cells were then washed three times with
PBS followed by incubation with Alexa-488 labeled sec-
ondary antibody (Thermo Fisher Scientific) at 1:250 dilu-
tion for 1 h at room temperature. After washing the
cells three times with PBS, the cells were stained with
DAPI using the VECTASHIELD hardset antifade mount-
ing medium with DAPI (Vector Laboratories, Inc., Bur-
lingame, CA). The images were taken at 10X
magnification on a Zeiss confocal microscope (LSM 710,
Carl Zeiss). Images were analyzed using ImageJ (v1.52a).
siRNA transfection
siRNAs against CFIm25 and CPSF73 were purchased
from Sigma-Aldrich. siRNAs against CstF-64 were pur-
chased from Sigma-Aldrich (CstF64.1) and Origene
Technologies Inc., Rockville, MD (CstF64.2 and
CstF64.3). siRNAs were transfected into fibroblasts or
cancer cells using GeneMute transfection reagent from
SignaGen Laboratories (Rockville, MD) according to the
manufacturer’s instructions.
Real-time PCR
For real-time PCR, DNA primers were designed with Pri-
mer3 for UBC primers or NCBI Primer-BLAST for all
other primers, and synthesized by Integrated DNA Tech-
nologies (Coralville, IA). RNA was isolated using the Pure-
Link RNA Kit (Thermo Fisher Scientific). cDNA was
treated with TURBO DNA-free™ Kit (Thermo Fisher Scien-
tific) to eliminate the remaining DNA. Real-time PCR was
performed with SYBR® Green One-Step Real-Time RT PCR
Kit (Thermo Fisher Scientific). Samples were cycled on a
BioRad CFX96 Real Time PCR instrument driving a Biorad
C1000 Thermal Cycler for 40 cycles. The ΔΔCt method
was used to determine the abundance of different PCR
products [115]. Values for each gene of interest were nor-
malized to UBC for the same sample. Primer sequences
were as follows: CstF64, 5’-GCAAGCTTCTATGCAGGGT
G-3′ and 5′-TTGCATCGGCACTTGAACTC-3′; CPSF73,
5′-GAAGTCGAGGGGAGGAGTCT-3′ and 5′-AGCTCC
AAGGGGTCGGAT-3′; CFIm25, 5′-GCACCATCAACCT
GTACCCTC-3′ and 5′-AGTAACACATGGGGTAGCCG-
3′; long INF2, 5′-GGAGGAGGTGTGTGTCATCG-3′ and
5′-CTCCTGCAGGGTTACTGGTG-3′; short INF2, 5′-G
CTGCGGAACGAGTTTATCG-3′ and 5′-GGAGGTGCT
GCTTAGGTGAG-3′; long BOC, 5′-TCAGCAACGTGAT
GATCTGTGA-3′ and 5′-CCGCTCTATGGTTTCAGGA
AGG-3′; short BOC 5′-CCTCATCTCTCCCACCCTGA
A- 3′ and 5′-TGAGGTTTTCCAAGGGCACAA-3′, UBC,
5′-TCTTGTTTGTGGATCGCTGTGA-3′ and 5′-CAGG
AGGGATGCCTTCCTTATC-3′.
Incucyte in vitro wound healing assays
For wound healing assays, fibroblasts were plated in the
wells of an Incucyte™ ImageLock™ 96-well plate (Essen
BioScience) and the WoundMaker™ tool was used to cre-
ate a denuded area in each well on the plate. The Incu-
Cyte™ ZOOM live-cell analysis system (Essen BioScience)
was used to automatically collect time-lapse images (pha-
se-contrast) and to quantify cell migration over time as
the density of cells in the denuded area relative to the
density of cells out of the denuded area (relative wound
density). Plots were determined to be statistically signifi-
cantly different based on repeated measures two-way
ANOVA with Dunnett’s multiple comparison test.
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Statistical analyses and plots
Statistical significance determinations were performed
with two-tailed tests for all analyses. For DESeq/DESeq2,
splicing, and DEXSeq, the software included multiple
hypothesis testing correction. All errors bars represent
standard deviations. For the Wilcoxon test, we checked
whether the data were normally distributed. We used
Fisher’s exact tests when sample sizes were low. Statis-
tical significance for t-tests was determined using Prism
(6.0f, GraphPad Software, La Jolla, CA). Statistical sig-
nificance for correlations were performed using the cor()
function in R. The hypergeometric test was performed
with dhyper() function in R. The Wilcoxon test was per-
formed with the Wilcox.test() function in R. Time series
analysis for migration assays was performed with Prism.
All bar graphs for RT-PCR and plots for migration as-
says were performed in Prism. All box plots and density
plots were generated with ggplot2 package [116]. Plots
for motif frequencies were generated in Prism.
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